The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

American Journal of Surgical Pathology - Tập 29 Số 9 - Trang 1228-1242 - 2005
Geert J.L.H. van Leenders1, Theodorus H. van der Kwast2, David J. Grignon3, Lars Egevad4, Glen Kristiansen5, Charlotte F. Kweldam1, Geert Litjens6, Jesse K. McKenney7, Jonathan Melamed8, N. Mottet9, Gladell P. Paner10, Hemamali Samaratunga11, Ivo G. Schoots12, Jeffry Simko13, Liang Cheng14, M Varma15, Anne Y. Warren16, Thomas M. Wheeler17, Sean R. Williamson18, Kenneth A. Iczkowski19
1Departments of Pathology
2Department of Pathology, Princess Margaret Cancer Center.
3Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
4Department of Laboratory Information Support Systems, University Health Network, Toronto, ON, Canada.
5Institute of Pathology of the University Hospital Bonn, Bonn, Germany.
6Diagnostic Image Analysis Group and the Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands
7Department of Pathology, Cleveland Clinic, Cleveland, OH;
8Department of Pathology, New York University, Langone Medical Center, New York, NY
9Department of Surgery, Jean Monnet University, Saint-Etienne, France.
10Department of Pathology, University of Chicago, Chicago, IL
11Department of Pathology, University of Queensland School of Medicine, and Aquesta Uropathology, St Lucia, QLD.
12Radiology and Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam.
13Department of Pathology, University of California, San Francisco, CA;
14Department of Surgical Pathology, Aichi Medical University, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
15Department of Cellular Pathology, University Hospital of Wales, Cardiff, Wales.
16Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
17Dept. of Pathology and Immunology Baylor College of Medicine Houston TX
18Department of Pathology, Henry Ford Health System and Wayne State University School of Medicine, Detroit, MI.
19Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Amin, 1994, Analysis of cribriform morphology in prostatic neoplasia using antibody to high molecular-weight cytokeratin., Arch Pathol Lab Med, 118, 260

Amin, 2005, Egevad, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens., Scand J Urol Nephrol, 39, 20, 10.1080/03008880510030923

Bailar, 1966, 3rd, Mellinger GT, Gleason DF. Survival rates of patients with prostatic cancer, tumor stage, and differentiation: preliminary report., Cancer Chemother Rep, 50, 129

Baisden, 1999, Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy., Am J Surg Pathol, 23, 918, 10.1097/00000478-199908000-00009

Bostwick, 1995, Collagenous micronodules in prostate cancer: a specific but infrequent diagnostic finding., Arch Pathol Lab Med, 119, 444

Brinker, 1999, Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression., Am J Surg Pathol, 23, 1471, 10.1097/00000478-199912000-00004

Cohen, 1994, Sampling of radical prostatectomy specimens: how much is adequate?, Am J Clin Pathol, 101, 250, 10.1093/ajcp/101.3.250

DiBlasio, 2003, Predicting clinical end points: treatment nomograms in prostate cancer., Semin Oncol, 30, 567, 10.1016/S0093-7754(03)00351-8

Egevad, 2005, Current practice of Gleason grading among genitourinary pathologists., Hum Pathol, 36, 5, 10.1016/j.humpath.2004.10.001

Epstein, 1985, Mucinous adenocarcinoma of the prostate gland., Am J Surg Pathol, 9, 299, 10.1097/00000478-198504000-00006

Epstein, 2000, Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made., Am J Surg Pathol, 24, 477, 10.1097/00000478-200004000-00001

Epstein, 2005, Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens., Scand J Urol Nephrol, 39, 34, 10.1080/03008880510030932

Gleason, 1966, Classification of prostatic carcinomas., Cancer Chemother Rep, 50, 125

Gleason, 1974, Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging., J Urol, 11, 58, 10.1016/S0022-5347(17)59889-4

Hodge, 1989, Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate., J Urol, 142, 71, 10.1016/S0022-5347(17)38664-0

Hall, 1992, Evaluation of radical prostatectomy specimens: a comparative analysis of sampling methods., Am J Surg Pathol, 16, 315, 10.1097/00000478-199204000-00001

Humphrey, 1998, Pseudohyperplastic prostatic adenocarcinoma., Am J Surg Pathol, 22, 1239, 10.1097/00000478-199810000-00009

Kunz, 2003, Should each core with prostate cancer be assigned a separate Gleason score?, Hum Pathol, 34, 911, 10.1016/S0046-8177(03)00338-1

Levi, 2000, Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy., Am J Surg Pathol, 24, 1039, 10.1097/00000478-200008000-00001

Mellinger, 1967, 3rd. The histology and prognosis of prostatic cancer., J Urol, 97, 331, 10.1016/S0022-5347(17)63039-8

Mellinger, 1977, Prognosis of prostatic carcinoma., Recent Results Cancer Res, 61-, 72

Mosse, 2004, The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens., Am J Surg Pathol, 28, 394, 10.1097/00000478-200403000-00014

Nelson, 1996, Prostatic carcinoma with abundant xanthomatous cytoplasm: foamy gland carcinoma., Am J Surg Pathol, 20, 419, 10.1097/00000478-199604000-00004

Pacelli, 1998, Prostatic adenocarcinoma with glomeruloid features., Hum Pathol, 29, 543, 10.1016/S0046-8177(98)90073-9

Pan, 2000, The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system., Am J Surg Pathol, 24, 563, 10.1097/00000478-200004000-00011

Partin, 1997, Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update., JAMA, 277, 1445, 10.1001/jama.1997.03540420041027

Poulos, 2005, Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites., Mod Pathol, 18, 228, 10.1038/modpathol.3800302

Ro, 1990, Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies., Hum Pathol, 21, 593, 10.1016/S0046-8177(96)90004-0

Rubin, 2004, Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?, Am J Surg Pathol, 28, 946, 10.1097/00000478-200407000-00016

Sehdev, 2001, Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma., Hum Pathol, 32, 494, 10.1053/hupa.2001.24322

Stamey, 1999, Biological determinants of cancer progression in men with prostate cancer., JAMA, 281, 1395, 10.1001/jama.281.15.1395

Steinberg, 1997, Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings., Am J Surg Pathol, 21, 566, 10.1097/00000478-199705000-00010

Tran, 2001, Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis., Am J Surg Pathol, 25, 618, 10.1097/00000478-200105000-00008